Last reviewed · How we verify

NCT05912985

Three Different Oxygenation Strategies in Bronchoscopy Procedures Under Sedation

Status unknown Last updated 27 June 2023
What this trial tests

trial testing different oxygenation methods in Bronchoscopy in 252 participants. Status unknown.

Timeline
28 March 2023
Primary endpoint
1 September 2023
1 March 2024

Quick facts

Lead sponsorAnkara City Hospital Bilkent
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment252
Start date28 March 2023
Primary completion1 September 2023
Estimated completion1 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

18 and older, any sex, with Bronchoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of study aims to determine which of the three different oxygenation strategies, including nasal cannula, modified nasopharyngeal cannula, and HFNO groups, is safer in patients undergoing bronchoscopy under sedation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bronchoscopy

Currently open trials in the same condition.

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05912985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing